# 4728
It was called, euphemistically, the `Canadian Problem’.
News of a controversial, yet unpublished, Canadian study that began to emerge last September suggesting those who had received a seasonal flu shot in the previous year were more susceptible to the pandemic H1N1 virus.
Helen Branswell, science and medical reporter for the Canadian Press, was among the first to report on it (see Branswell On The Canadian Flu Shot Controversy).
In a matter of days a number of Canadian Provinces halted or announced delays in rolling out the seasonal flu shot, even though the study had yet to be published (see Ontario Adjusts Vaccination Plan).
The CDC and the World Health Organization, meanwhile, stated they saw no evidence in their data to suggest a link, but that they were continuing to investigate the matter.
Since then we’ve seen conflicting information.
In early October we saw a study published in the BMJ (British Medical Journal) that suggested exactly the opposite - that getting the seasonal flu vaccination may be slightly protective against the swine flu (see When Studies Collide).
Which, admittedly, ran contrary to what we’d heard previously from the CDC, who maintained that the seasonal vaccine was not expected to offer any protection against the novel H1N1 swine flu virus.
By November, with no compelling corroboration of the `Canadian Problem’, Canada’s National Advisory Committee on Immunization (NACI) came out in favor of resuming seasonal flu jabs (see NACI: Canada Should Resume Seasonal Flu Vaccinations).
In April, writing for CIDRAP, Maryn McKenna wrote of the publication of these four controversial studies in PLoS Medicine.
New Canadian studies suggest seasonal flu shot increased H1N1 risk
Maryn McKenna
Contributing Writer
Apr 6, 2010 (CIDRAP News) – Despite a rapidly launched range of studies, investigators in Canada are still unable to say—or to rule out—whether receiving a seasonal flu vaccination in the 2008-09 season made it more likely that Canadians would become ill from 2009 pandemic H1N1 flu.
Which brings us, today, to a newly published study in Eurosurveillance on a household study conducted in Australia on the very issue.
A hat tip to Ironorehopper on FluTrackers for posting this link.
Eurosurveillance, Volume 15, Issue 28, 15 July 2010
Rapid communications
D Carcione, C Giele, L S Goggin, K S Kwan, D W Smith, G K Dowse, D B Mak, P Effler
We conducted a prospective household transmission study to examine whether receipt of 2009 trivalent influenza vaccine (TIV) was associated with increased risk of influenza-like illness (ILI) among contacts of confirmed pandemic influenza A(H1N1) 2009 patients.
In the week following onset of pandemic illness in a household member, 46 (15%) of 304 TIV-vaccinated contacts, and 174 (15%) of 1,162 unvaccinated contacts developed ILI (p= 0.95).
Receipt of 2009 TIV had no effect on one’s risk of pandemic illness.
Although one would hope for a definitive, etched-in-stone answer here, as always there are limitations to this study. In the author’s discussion, they write:
Several limitations of our study should be noted. First, the outcome sought was clinical ILI and not laboratory-proven influenza. Only a small subset of household contacts who developed ILI were tested for influenza; however, a high proportion of the contacts tested by PCR within two days of developing ILI were confirmed as having pandemic influenza A(H1N1) 2009 infection.
Second, vaccination histories were not verified through medical records. Most seasonal 2009 TIV vaccinations would have been administered between the months of March and June 2009, and interviews to determine vaccination status were conducted between late May and early August 2009. Whilst errors in recall may have occurred, it seems reasonable to assume that were this the case such errors would be similar among the cohort who later developed ILI, compared to those who did not.
While this study did not find an association – either positive or negative – to prior inoculation and contracting novel H1N1, the authors regard this as an interim analysis.
No doubt, this is a subject that will command additional study and analysis. For now, however, if there is an association . . . it doesn’t appear to be pervasive.
Related Post:
- Anticipating The Flu Season Down Under
- Dr. Alan Hampson Interview On Indonesia’s New Bird Flu Clade
- NSW: Hen Facility Quarantined Under Suspicion Of Avian Influenza
- Queensland: A Hendra Watch & A New Vaccine
- CSIRO: The Quest For Flu Resistant Poultry
- The 2012 Flu Season Down Under
- CSL: Report On Febrile Reactions To FluVax
- Australia Finds LPAI H5 On Two Duck Farms
- Prof. Peter Doherty On Influenza’s Threat
- Another Yank From Oxford
- ECDC: Risk Assessment On Australia’s Antiviral Resistant H1N1 Cluster
- The Flu Season Down Under
- Australia: Dog Tests Positive For Hendra Virus
- Australia: Flu Season Nearing Peak - ISG
- MJA: Safety Of Flu Shot In Young Children
- A Sexually Transmitted Disease Cure
- Yasi Makes Landfall On Queensland Coast
- Ain’t We Got Fund?
- Australia: Panvax Investigated For Febrile Convulsions
- Australia: No Clear Answers On Child’s Death
- The Uptake Down Under
- Australia Lifts Ban On Flu Vax For Under Five’s
- Study: Pandemic Mitigation by Early School Closure
- NZ And Australia Seeing Increase In Flu-Like Illnesses
- Canada Releases Tamiflu From National Emergency Stockpile
- Canada: FluWatch Week 52
- Canada: Another West Coast Temblor
- Haida Gwaii Quake & Tsunami Advisories
- Novartis Fluad And Agriflu Vaccines Suspended In Canada
- Ontario Confirms H1N1v Case
- EID Journal: Revisiting The `Canadian Problem’
- Alberta, Canada Issues Measles Alert
- IDSA: Educational Guidelines Lower Antibiotic Use
- Webinar: pH1N1 – H3N2 A Novel Influenza Reassortment
- North America Flu Surveillance Week 8
- North America Influenza Surveillance - Week 4
- North America: Flu Surveillance Week 2
- North America: Flu Activity Week 1
- Toronto ERs Seeing Heavy Flu Volume
- North America: H3N2 Driving Our Flu Season
- PHAC: Lessons Learned From The 2009 Pandemic
- Ontario: A Top Ten List Of Infectious Disease Threats
- Eurosurveillance: The Temporary Immunity Hypothesis
- OIE Report: Manitoba Bird Flu Identified As H5N2
- CFIA Statement On Manitoba’s Avian Flu Outbreak
- CTV Reporting Low Path H5 On Canadian Turkey Farm
- CMAJ: Comparing First And Second Pandemic Waves In Canada
- CSA White Paper: Voices From The Front Lines
- Eurosurveillance: Hajj Health Hazards & Recommendations
- Eurosurveillance: Cross Reactive Antibodies to H3N2v In Norway
- Eurosurveillance: Older People May Be Susceptible To The H3N2v Virus
- Two New Swine trH3N2 Studies To Ponder
- Eurosurveillance: New Research On Pandemic Influenza
- Eurosurveillance: Avian Flu In Humans -Insights From A Line List
- Measles: Forgotten, But Not Gone
- Eurosurveillance: Debating The D222G/N Mutation In H1N1
- Eurosurveillance: Another Pandemic Vaccine Effectiveness Study
- Eurosurveillance: Analysis Of Fatal H1N1 Cases In The UK
- Eurosurveillance: The Temporary Immunity Hypothesis
- Eurosurveillance On Antimicrobial Resistance
- Eurosurveillance: More On H1N1 Mutations
- Eurosurveillance On Recently Isolated H1N1 Mutations
- Eurosurveillance: Looking Ahead to the 2010-11 Flu Season
- Eurosurveillance: 500 H5N1 Cases After 6 1/2 Years
- Hantavirus: An Emerging Infectious Disease
- Eurosurveillance: Adverse Effects of Oseltamivir in Children
- Japan: Quarantine At Ports Ineffective Against Pandemic Flu
- Roundup Of H1N1 Studies From Eurosurveillance
- Study: H1N1 Hospitalization Profiles
- Eurosurveillance: Pandemic H1N1 In The Southern Hemisphere
Widget by [ Iptek-4u ]